Submitted by Anonymous (not verified) on 9 March 2026 - 10:44
Human medicines European public assessment report (EPAR): Winrevair, sotatercept, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Winrevair, sotatercept, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised